Subscribe to RSS
DOI: 10.1055/s-0030-1256163
© Georg Thieme Verlag KG Stuttgart · New York
A rare case of peripancreatic Castleman’s disease diagnosed preoperatively by endoscopic ultrasound-guided fine needle aspiration
Dr. S. Giday
Center for Digestive Health
1817 North Mills Avenue
Orlando
FL
32803
USA
Fax: 4078960612
Email: samgiday@gmail.com
Publication History
Publication Date:
18 March 2011 (online)
Castleman’s disease is a rare lymphoproliferative disorder of unknown etiology and has three pathologic variants: hyaline-vascular (HV), plasma cell (PC), and mixed type [1]. Two clinically relevant subtypes exist, the unicentric and multicentric variants. Unicentric pancreatic Castleman’s disease is very rare with only 13 reported cases [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14]. We report on the endosonographic features of pancreatic Castleman’s disease and its preoperative diagnosis by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA).
A 27-year-old woman had a 4.2 × 4.3 cm, exophytic, hypervascular mass on arterial phase computed tomography (CT) ([Fig. 1]), which washed out on the venous phase images.


Fig. 1 Dual-phase computed tomography (CT) angiogram with three-dimensional (3D) mapping demonstrating a hypervascular mass arising from near the neck/body of the pancreas with increased vascularity: a maximum intensity projection and b volume rendered arterial phase images. The focus of calcification was also defined.


EUS revealed a hypoechoic and hypervascular peripancreatic mass with a punctate calcification ([Fig. 2]).


Fig. 2 Endoscopic ultrasound (EUS) showing a 41.6 × 25.1 mm, hypoechoic, homogeneous, and round peripancreatic mass with sharp borders. a The mass had a punctate calcification (arrow) with posterior shadowing.


Fig. 2 b EUS-guided fine needle aspiration (FNA) of the mass showed hypervascularity with power flow.
EUS-FNA was carried out and cytologic examination with flow cytometric analysis revealed polymorphous lymphocytes with a predominance of B lymphocytes, comprising a mixture of κ- and λ-bearing cells. Occasional morphologic features on cytologic smears (presence of variably sized and partially intact lymphoid follicles with traversing capillary vessels) and on cell block section (numerous lymphoid follicles with characteristic concentric rimming of lymphocytes) were compatible with a diagnosis of Castleman’s disease ([Fig. 3]).


Fig. 3 Fine needle aspiration cytology shows a partially intact lymphoid follicle with a piercing fine capillary vessel. Background has polymorphous lymphocytes (Papanicolaou stain, × 200).
Laparotomy with excision of pancreatic mass was carried out without the need for pancreatic resection. Pathologic examination was consistent with an enlarged lymph node. The overall nodal architecture was preserved and there were numerous small follicles. Many of the follicles were atretic, and some contained two or more germinal centers. There was prominent concentric layering of peripheral lymphocytes around the follicles, creating an onion-skin pattern ([Fig. 4]). Hyaline deposits were present in many of the follicles. Interfollicular vascular proliferation was present, with some of the vessels penetrating the follicles, creating “lollipop” lesions. These characteristic pathologic features were consistent with a diagnosis of unicentric peripancreatic Castleman’s disease, HV variant.


Fig. 4 Histopathologic section displaying follicles with germinal centers lined by concentric layering of lymphocytes (“onion skinning”) and containing sclerotic vessels in the center (hematoxylin and eosin stain, × 100).
In all but one of the reported pancreatic Castleman’s disease cases ([Table 1]) [12], the diagnosis was established after histopathologic examination of surgically resected specimens.
Study | Location | Symptoms | Subtype | Treatment | EUS features | Preoperative impression/diagnosis |
Lepke et al. (1982) [2] | BOP | None | HV | DP | NA | None |
LeVan et al. (1989) [3] | TOP | Back pain | HV | DP | NA | None |
Brossard et al. (1992) [4] | TOP | Systemic | PC | DP | NA | None |
Corbisier et al. (1993) [6] | Peripancreatic | Abdominal pain | HV | Excision | NA | None |
Baikovas et al. (1994) [5] | Peripancreatic | None | HV | Excision | NA | None |
Le Borgne et al. (1999) [7] | Uncinate | Systemic | PC | Whipple | NA | None |
Erkan et al. (2004) [8] | Peripancreatic | Abdominal pain | PC | Enucleation | NA | None |
Goetze et al. (2005) [9] | TOP | None | HV | DP | Hypoechoic, well circumscribed, calcified (nondiagnostic EUS-FNA) | None |
Su et al. (2005) [11] | Peripancreatic | Abdominal pain | HV | Excision | NA | PNET |
Wang et al. (2007) [10] | HOP | None | HV | Whipple | Not reported (nondiagnostic EUS-FNA) | None |
Tunru-Dinh et al. (2007) [14] | TOP | Abdominal pain | HV | DP | NA | None |
Rhee et al. (2008) [12] | Peripancreatic | None | HV | Excision | Hypoechoic, homogeneous, well-delineated, hypervascular | Castleman’s disease (by EUS-trucut biopsy) |
Charalabopoulos et al. (2010) [13] | BOP | Abdominal pain | PC | DP | NA | None |
BOP, body of pancreas; TOP, tail of pancreas; HV, hyaline-vascular type; PC, plasma cell type; DP, distal pancreatectomy; EUS-FNA, endoscopic ultrasound fine needle aspiration; NA, not applicable; PNET, pancreatic neuroectodermal tumor. |
Rhee et al. described preoperative diagnosis of pancreatic Castleman’s disease using EUS-guided trucut biopsy (TCB) [12]. However, EUS-TCB can be technically challenging, especially in the case of pancreatic head lesions, due to the stiffness of the needle. Two other reports described nondiagnostic preoperative EUS-FNA [9] [10]. The current report is the first study to suggest a positive yield of EUS-FNA for the preoperative diagnosis of Castleman’s disease. Preoperative diagnosis of Castleman’s disease is important for patient reassurance, avoidance of unnecessary neoadjuvant therapy, and appropriate surgical planning. Castleman’s disease should be considered in the differential diagnosis of pancreatic/peripancreatic masses. Radiographic and endosonographic characteristics of Castleman’s disease are not specific and cases may display central calcifications. EUS-FNA may be a valuable tool in establishing a preoperative diagnosis.
Endoscopy_UCTN_Code_CCL_1AF_2AZ_3AD
Competing interests: None
#References
- 1 Keller A R, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29 670-683
- 2 Lepke R A, Pagani J J. Pancreatic Castleman disease simulating pancreatic carcinoma on computed tomography. J Comput Assist Tomogr. 1982; 6 1193-1195
- 3 LeVan T A, Clifford S, Staren E D. Castleman’s tumor masquerading as a pancreatic neoplasm. Surgery. 1989; 106 884-887
- 4 Brossard G, Ollivier S, Pellegrin J L et al. Pancreatic Castleman’s tumor revealed by prolonged fever. Presse Med. 1992; 21 86
- 5 Baikovas S, Glenn D, Stanton A et al. Castleman’s disease: an unusual cause of a peri-pancreatic hilar mass. Aust N Z J Surg. 1994; 64 219-221
- 6 Corbisier F, Ollier J C, Adloff M. Pancreatic localization of a Castleman’s tumour. Acta Chir Belg. 1993; 93 227-229
- 7 Le Borgne J, Joubert M, Emam N et al. Pancreatic localization of Castleman’s tumor. Gastroenterol Clin Biol. 1999; 23 536-538
- 8 Erkan N, Yildirim M, Selek E et al. Peripancreatic Castleman disease. JOP. 2004; 5 491-494
- 9 Goetze O, Banasch M, Junker K et al. Unicentric Castleman’s disease of the pancreas with massive central calcification. World J Gastroenterol. 2005; 11 6725-6727
- 10 Wang H, Wieczorek R L, Zenilman M E et al. Castleman’s disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome. World J Surg Oncol. 2007; 5 133
- 11 Su I H, Wan Y L, Pan K T et al. Symptomatic mesentery Castleman disease mimicking a pancreatic tumor. Clin Imaging. 2005; 29 348-351
- 12 Rhee K H, Lee S S, Huh J R. Endoscopic ultrasonography-guided trucut biopsy for the preoperative diagnosis of peripancreatic Castleman’s disease: a case report. World J Gastroenterol. 2008; 14 2115-2117
- 13 Charalabopoulos A, Misiakos E P, Foukas P et al. Localized peripancreatic plasma cell Castleman disease. Am J Surg. 2010; 199 e51-e53
- 14 Tunru-Dinh V W, Ghani A, Tom Y D. Rare case of Castleman disease involving the pancreas. Am J Surg. 2007; 73 1284-1287
Dr. S. Giday
Center for Digestive Health
1817 North Mills Avenue
Orlando
FL
32803
USA
Fax: 4078960612
Email: samgiday@gmail.com
References
- 1 Keller A R, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29 670-683
- 2 Lepke R A, Pagani J J. Pancreatic Castleman disease simulating pancreatic carcinoma on computed tomography. J Comput Assist Tomogr. 1982; 6 1193-1195
- 3 LeVan T A, Clifford S, Staren E D. Castleman’s tumor masquerading as a pancreatic neoplasm. Surgery. 1989; 106 884-887
- 4 Brossard G, Ollivier S, Pellegrin J L et al. Pancreatic Castleman’s tumor revealed by prolonged fever. Presse Med. 1992; 21 86
- 5 Baikovas S, Glenn D, Stanton A et al. Castleman’s disease: an unusual cause of a peri-pancreatic hilar mass. Aust N Z J Surg. 1994; 64 219-221
- 6 Corbisier F, Ollier J C, Adloff M. Pancreatic localization of a Castleman’s tumour. Acta Chir Belg. 1993; 93 227-229
- 7 Le Borgne J, Joubert M, Emam N et al. Pancreatic localization of Castleman’s tumor. Gastroenterol Clin Biol. 1999; 23 536-538
- 8 Erkan N, Yildirim M, Selek E et al. Peripancreatic Castleman disease. JOP. 2004; 5 491-494
- 9 Goetze O, Banasch M, Junker K et al. Unicentric Castleman’s disease of the pancreas with massive central calcification. World J Gastroenterol. 2005; 11 6725-6727
- 10 Wang H, Wieczorek R L, Zenilman M E et al. Castleman’s disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome. World J Surg Oncol. 2007; 5 133
- 11 Su I H, Wan Y L, Pan K T et al. Symptomatic mesentery Castleman disease mimicking a pancreatic tumor. Clin Imaging. 2005; 29 348-351
- 12 Rhee K H, Lee S S, Huh J R. Endoscopic ultrasonography-guided trucut biopsy for the preoperative diagnosis of peripancreatic Castleman’s disease: a case report. World J Gastroenterol. 2008; 14 2115-2117
- 13 Charalabopoulos A, Misiakos E P, Foukas P et al. Localized peripancreatic plasma cell Castleman disease. Am J Surg. 2010; 199 e51-e53
- 14 Tunru-Dinh V W, Ghani A, Tom Y D. Rare case of Castleman disease involving the pancreas. Am J Surg. 2007; 73 1284-1287
Dr. S. Giday
Center for Digestive Health
1817 North Mills Avenue
Orlando
FL
32803
USA
Fax: 4078960612
Email: samgiday@gmail.com


Fig. 1 Dual-phase computed tomography (CT) angiogram with three-dimensional (3D) mapping demonstrating a hypervascular mass arising from near the neck/body of the pancreas with increased vascularity: a maximum intensity projection and b volume rendered arterial phase images. The focus of calcification was also defined.




Fig. 2 Endoscopic ultrasound (EUS) showing a 41.6 × 25.1 mm, hypoechoic, homogeneous, and round peripancreatic mass with sharp borders. a The mass had a punctate calcification (arrow) with posterior shadowing.


Fig. 2 b EUS-guided fine needle aspiration (FNA) of the mass showed hypervascularity with power flow.


Fig. 3 Fine needle aspiration cytology shows a partially intact lymphoid follicle with a piercing fine capillary vessel. Background has polymorphous lymphocytes (Papanicolaou stain, × 200).


Fig. 4 Histopathologic section displaying follicles with germinal centers lined by concentric layering of lymphocytes (“onion skinning”) and containing sclerotic vessels in the center (hematoxylin and eosin stain, × 100).